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In the 1980s and early 1990s, asthma prevalence increased significantly in most Westernized countries. In more recent years, asthma trends have been less clear, with some studies suggesting that they are still rising and others suggesting that they have stabilized or decreased. A population-based cohort study was conducted to estimate asthma prevalence and incidence trends in one large Canadian province, Ontario. All individuals with asthma living in Ontario, a province of Canada with a multicultural population of approximately 12 million, were identified in universal, population health administrative databases by using a validated health administrative case definition of asthma. Annual asthma prevalence, incidence, and all-cause mortality rates were estimated from 1996 to 2005. During this time, the prevalence of asthma increased by 70.5%. The age-and sex-standardized asthma prevalence increased from 8.5% in 1996 to 13.3% in 2005, a relative increase of 55.1% (P < 0.0001). Asthma incidence rates increased in children by 30 .0% and were relatively stable in adults. Overall all-cause mortality decreased. Asthma prevalence in Ontario, Canada, has increased significantly. This is attributable, in part, to an increase in the incidence of asthma in children. Effective clinical and public health strategies are needed to prevent and manage asthma in the population. asthma; incidence; population; prevalence Asthma is the most common chronic respiratory disease in the world and one of the most common chronic diseases among children (1) . In the 1980s and early 1990s, asthma prevalence appeared to increase significantly in most Westernized countries (2) . In more recent years, however, trends have been less clear, with some studies suggesting that asthma prevalence has continued to increase and others suggesting that it has stabilized or decreased (2) (3) (4) (5) (6) (7) (8) . This uncertainty has been made worse by the fact that many asthma prevalence studies, with some notable exceptions, have focused on different specific groups of individuals, such as school children or young adults, who might not be comparable (7, 9, 10) . As a result, there is still a lot to be learned about asthma trends in populations overall.
Besides there being gaps in knowledge about trends in prevalence, there is also little known about trends in asthma incidence and all-cause mortality (as opposed to asthmaspecific mortality) (11, 12) . Incidence is directly and mortality inversely related to prevalence. More knowledge about trends in asthma prevalence, incidence, and all-cause mortality in the population would be instrumental in helping health-care providers and decision makers anticipate the burden of asthma and optimize clinical and public health strategies for individuals with asthma accordingly.
To fill the above gaps in knowledge, we conducted the current study to estimate overall trends in asthma prevalence, incidence, and all-cause mortality in a large Canadian province. We aimed to quantify the change in asthma prevalence over time and by gender and various age groups.
MATERIALS AND METHODS

Data sources
Our study was based in Ontario, Canada, which has a large, diverse, multicultural population of more than 12 million residents that constitutes more than one-third of Canada's population. Canada is considered a high-incidence country for asthma (1) . Ontario has a universal, single-payer health-care system that covers all physician and hospital services, and the personal health information collected for the administration of this system is available in a few large databases. The Ontario Health Insurance Plan Database contains information on all fee-for-service billings for physician services rendered in Ontario, including a diagnosis, since July 1, 1991. The Canadian Institute for Health Information Database records the primary diagnosis and up to 15 secondary diagnoses for all patients discharged from acute-care hospitals prior to 2002 and up to 25 secondary diagnoses in 2002 and later years. The Ontario Registered Persons Database includes information on gender, birth date, residence postal code, and, if applicable, date of death. Deaths recorded in the Registered Persons Database are based on probabilistic linkage of death certificate information. Therefore, to ensure that no deaths were missed, we also recorded deaths that occurred in the hospital and, where discrepancies in dates of death existed between the 2 sources, the hospital date was used. We linked these databases together on an individual level using an encrypted version of the unique Ontario health insurance number given to all Ontario residents. Such linkage allows for protection of the identities of individuals while examining their health services use across health administrative databases.
Study population and definition of asthma
The Ontario Asthma Surveillance Information System Database is a validated registry of all Ontario residents with asthma that was generated by using the Ontario Health Insurance Plan and Canadian Institute for Health Information health administrative databases described above. For generation of the database, all individuals with asthma were identified by using a previously validated asthma case definition described in detail elsewhere and used in previous studies (13) (14) (15) (16) . This case definition of at least 2 asthma physician visits within 2 consecutive years and/or at least 1 asthma hospitalization yielded 89% sensitivity and 72% specificity in children (aged 0-17 years) and 84% sensitivity and 76% specificity in adults (aged 18 years or over). Once entered into the database, patients remained part of the asthma population until they moved out of the province or died in order to be consistent with previous evidence indicating that asthma, once diagnosed, may remit but does not resolve (17, 18) .
Outcomes
Our primary outcome was change in the age-and sexstandardized prevalence of asthma between fiscal year 1991 (from April 1, 1991 , to March 31, 1992 ) and fiscal year 2005 (from April 1, 2005, to March 31, 2006). Secondary outcomes were changes in the age-and sex-standardized incidence of asthma and all-cause mortality in individuals with asthma over the same time period. All-cause mortality was used because information on disease-specific mortality was not available.
Analysis
We used methods consistent with those of other studies examining prevalence trends of chronic disease using health administrative data (19) (20) (21) . Using the asthma case definition, we estimated annual prevalence in the population from fiscal year 1996 to fiscal year 2005 by dividing the number of patients with asthma in each fiscal year by the census population estimate in the corresponding year (22) .
We chose to start reporting results in fiscal year 1996 to allow for sufficient time to identify prior prevalent cases of asthma, and we chose the end date of fiscal year 2005 to allow for a 2-year ''look forward'' period to meet the terms of the validated case-definition algorithm.
Asthma incidence rates were calculated for 5 time periods (1996-1997, 1998-1999, 2000-2001, 2002-2003, and 2004-2005) by dividing the number of incident asthma cases by the number of patient-years of individuals still at risk of developing asthma. Two-year intervals were used so results would be more stable. To confidently distinguish an incident case from a prevalent case, we set a minimum asthma-free observation period of 5 years prior to the incidence date as a requirement. For example, a person meeting the case definition of asthma in fiscal year 2000-2001 must have had no asthma claim during the previous 5 years to be included as an incident case. If he or she had a claim during this time, it was presumed that asthma had previously been considered and that he or she was included as a prevalent, but not an incident, case. The period of 5 years was chosen on the basis of clinical knowledge and previous chronic disease surveillance studies (20, 21, 23) . Having a ''look-back'' period (the same for all individuals so they were treated equally) avoided incidence rates being artificially inflated because of the inclusion of a small number of misclassified prevalent cases. Children born in Ontario after April 1, 1991, were exempt from this rule, because their entire lifetimes were available, which could indicate clearly if they had a prior asthma diagnosis. Incidence of asthma prior to 1996 was not estimated because the 5-year lookback period was not available.
The 5-year look-back period helped to distinguish incident asthma from prevalent asthma during the study period; however, it did not account for individuals diagnosed with asthma prior to 1991; therefore, we applied a second adjustment to our estimates. Because we could not identify individuals with asthma prior to 1991 nor avoid having them possibly show up after a long period of remission as ''incident cases,'' we applied a correction factor that removed them from our estimates. Specifically, for each 2-year period, we used our asthma cohort to calculate the likelihood of individuals being incident cases prior to our study and then subtracted this amount from our incidence estimate. We calculated the likelihood of individuals being incident cases prior to our study or their previous lifetime risk of developing asthma, by using a modified survival analysis technique described by Beiser et al. (24) and used previously to measure lifetime risk of asthma (refer to Appendix for details) (16) . This approach likely overestimated the number of individuals with asthma diagnosed prior to 1991 and provided conservative estimates of the incidence of asthma.
We estimated annual all-cause mortality in the asthma population during fiscal years 1996-2005 by dividing the number of deaths among individuals with asthma by the number of individuals with asthma in each fiscal year. We used all-cause mortality because information on diseasespecific mortality was not available.
To compare prevalence, incidence, and mortality rates over time, we standardized them for age and sex using 2005 Ontario census population estimates. We calculated the relative percentage change in rates between 2 fiscal years using the rate in the earlier fiscal year as the reference. We also tested for trends over time using the CochranArmitage trend test. Finally, we used logistic regression models to test for interactions among age, sex, and fiscal year and, because interaction terms were found to be significant, we stratified the analysis by age and sex. To compare trends between sexes and age groups, we standardized sexspecific rates for age and age-specific rates for sex using Ontario 2005 census data (25) . We compared rates among fiscal years, sexes, and age groups using chi-squared analyses. We compared percentage changes in rates from fiscal year 1996 to fiscal year 2005 between sexes and age groups using Cochran-Mantel-Haenszel and Breslow-Day tests.
Sensitivity analysis
To test the rigor of our results, we reconstructed the asthma cohort using a second previously validated health administrative case definition of asthma shown to have about 11%-12% higher specificity than the case definition used in the primary analysis (84% and 87% specificity in children and adults, respectively). Unfortunately, as is often the case, there was a tradeoff between specificity and sensitivity, so that the sensitivity of this new case definition was about 10% lower than that of the case definition used in the primary analysis (80% and 74% sensitivity in children and adults, respectively) (13) (14) (15) . We then recalculated change in prevalence.
Ethics statement
Ethics approval was obtained from the institutional review boards at The Hospital for Sick Children and Sunnybrook Health Sciences Centre, Toronto, Ontario.
RESULTS
Asthma prevalence
The number of individuals with asthma increased by 70.5% from 1996 to 2005. This increase was significantly greater than the population growth of 13.2% during the same time period. The age-and sex-standardized prevalence increased from 8.5% in 1996 to 13.3% in 2005, which was a 55.1% relative increase (P < 0.001). Most of the increase was seen in the first part of the study period, approaching a plateau in the later part (Table 1; Figure 1) .
The sex-standardized increase in prevalence was greatest in adolescents and young adults compared with other age groups (P < 0.001), while it appeared to be decreasing in children 4 years of age or less. The age-standardized increase in prevalence was greater in males compared with females (P < 0.001). Compared with females, males experienced higher increases in prevalence in adolescence and young adulthood and lower increases at age 70 years or older (Table 1; Figure 1 ).
Asthma incidence
From 1996 to 1999, the overall age-and sex-standardized incidence rate of asthma increased from 5.0/1,000 personyears to 5.7/1,000 person-years, a relative increase of 14.0% (P < 0.001). This increase was mainly due to a 30% increase in children aged 14 years or younger. After 1999, the incidence rates remained relatively stable in children and modestly decreased (P < 0.001) in all other age groups (Table 2; Figure 2 ).
Mortality
The overall age-and sex-standardized all-cause mortality rates were very low. They decreased from 887.6/100,000 individuals in 1996 to 730.0/100,000 individuals in 2005, which was a relative decrease of 17.8% (P < 0.001) ( Table 3 ). 
Sensitivity analyses
Using a health administrative case definition of asthma with high specificity (but limited sensitivity) to calculated prevalence trends, we found that the number of individuals with asthma increased by 63.5%. This corresponded to an age-and sex-standardized relative prevalence increase of 44.5%.
DISCUSSION
We conducted a population-based study of all individuals living in Ontario, Canada, and found that, after standardization by age and sex, the prevalence of asthma increased by 55.1% between 1996 and 2005. Most of the increase was seen in the beginning, with trends approaching a plateau in the later years of the study. Even when a definition of asthma with high specificity (but limited sensitivity) was used, the increase in prevalence remained high. Overdiagnosis of asthma in the later years of the study could not have been responsible for this increase, because overall incidence rates increased by only 1.6%. A 30% increase in the incidence of asthma in children and low mortality overall, however, likely contributed to the increase in prevalence seen. To the best of our knowledge, this is the first large study to examine asthma prevalence trends in an entire population. Such a large increase, especially in children, is concerning, and more research is needed to determine why it is occurring and how it can be reversed. These findings stress the importance of having clinical and public health strategies to effectively prevent and manage this very common disease.
The increasing prevalence and incidence found in our study are consistent with those of others, including one using Statistics Canada data, that have shown similar increasing trends (2, 4-6, 8, 26) . They are also consistent with, and appear to be a continuation of, increasing asthma prevalence trends in the 1980s and early 1990s (2) . The cause of increasing asthma prevalence has puzzled researchers for years and still remains unknown. Proposed contributing factors have included exposure to air pollution, infections, and microbial substances in the environment (2). Allergy is one potential etiologic factor that has become more common in Ontario over the last decade and could have contributed to the increases seen (5). Obesity, more controversially, is another (27) . Although the prevalence of asthma in our study did level off in later years, the overall increasing trend we found differed from results from other studies that demonstrated a stabilization or decrease in asthma prevalence during the same time period. As alluded to above, this might have been because our study focused on the entire population, while other studies examined only specific groups, such as school children. It might also have been because our study measured asthma of a different severity from that of others (26, 28) . For example, our study might have captured individuals with milder asthma-whose prevalence was increasing-while other studies measured more severe asthma whose prevalence was decreasing.
Another reason why our study differed from others might have been because it used health administrative data as opposed to survey data to estimate asthma prevalence. Survey data, unlike health administrative data which are collected at the time of diagnosis, are dependent on individuals' memories and subject to recall bias (being more likely to remember recent as opposed to remote events) (8) . Such recall bias in other studies might have meant that their ''prevalent asthma'' was more likely to represent recently diagnosed, as opposed to remotely diagnosed, asthma and, therefore, might have been a closer approximation of the ''incident'' (rather than the ''prevalent'') asthma measured in our study, which we also found to be stable/modestly decreasing. Lack of agreement between survey and health administrative data (which has been described in the literature) is also the reason why we hesitate to make direct, absolute prevalence comparisons between this and other studies (29) . For example, our overall asthma prevalence in 2005 (13.3%) was higher than the prevalence found in the 2005 National Health Survey done in the United States of 11.2% (30) . We suspect that much of the difference between these values is due to different methods of measurement and not large differences in the populations; however, this would need to be confirmed by further study.
The strengths of our study were its use of large, comprehensive health administrative databases of the entire population to identify individuals with asthma (using a validated case definition) and being able to follow them over time. Its main limitation was its use of physician-diagnosed asthma, which may have been subject to some misclassification bias. Nonetheless, we believe that any such bias would have been consistent over the years studied and be unlikely to affect prevalence trends that were the main outcome of our study. Indeed, others have compared asthma health administrative and survey data and found that, while there were differences in absolute values, health administrative data were consistent over time and therefore reliable for studying asthma trends (29) . In order to ensure that misclassification did not play a prominent role in determining asthma trends, we repeated the analysis using a health administrative case definition of asthma with high specificity (but limited sensitivity) and found very similar results.
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